The Role of Oxidative Stress in Patients with Recurrent Pregnancy Loss: a Review
Overview
Affiliations
Background: Recurrent pregnancy loss (RPL) presents one of the main problems in the field of reproductive medicine, due to the unknown etiology in 50% of cases, as well as limited evidence-based diagnostic and therapeutic modalities. Recent studies indicate that systemic and placental oxidative stress (OS) represents an essential factor in the etiopathogenesis of RPL. This article is a comprehensive narrative synthesis of previously published studies concerning the role of oxidative stress in the etiology of recurrent pregnancy loss.
Methods: We conducted literature search of published studies in the English language focusing on oxidative stress and its association with recurrent pregnancy loss (RPL) utilizing the Medline and Cochrane databases from 2000 through January 2021. The keywords used were "recurrent pregnancy loss" "oxidative stress and recurrent pregnancy loss" and "oxidative stress biomarkers and recurrent pregnancy loss".
Results: The search yielded 1116 publications, of which 92 were included in the final analysis. Reactive oxygen species (ROS) and reactive nitrogen species (RNS) at basal levels have various physiological functions whereas deviation from redox window is associated with different pathologies including early pregnancy loss. The currently available studies support the concept that increased oxidative stress (OS) and deficient antioxidant protection is implicated in the etiology of recurrent pregnancy loss (RPL) but underlying mechanisms through which OS affects pregnancy outcome remains largely indefinable.
Conclusions: Future research in this field can provide new insights regarding the OS-mediated damage in recurrent pregnancy loss as well as potential applications of antioxidant therapy in this group of patients.
Zhou H, Zhou J, Liu S, Niu J, Pan J, Li R Redox Biol. 2025; 80:103508.
PMID: 39908863 PMC: 11847473. DOI: 10.1016/j.redox.2025.103508.
Pourmontaseri H, Bazmi S, Sepehrinia M, Mostafavi A, Arefnezhad R, Homayounfar R Front Nutr. 2025; 11:1497364.
PMID: 39885868 PMC: 11781229. DOI: 10.3389/fnut.2024.1497364.
Micronutrient-Antioxidant Therapy and Male Fertility Improvement During ART Cycles.
Lahimer M, Capelle S, Lefranc E, Bosquet D, Kazdar N, Ledu A Nutrients. 2025; 17(2).
PMID: 39861453 PMC: 11768505. DOI: 10.3390/nu17020324.
Saleh R, Sallam H, Elsuity M, Dutta S, Sengupta P, Nasr A Front Endocrinol (Lausanne). 2025; 15():1503905.
PMID: 39850484 PMC: 11756326. DOI: 10.3389/fendo.2024.1503905.
Oxidative stress and its role in recurrent pregnancy loss: mechanisms and implications.
Zhang X, Gao J, Yang L, Feng X, Yuan X J Mol Histol. 2024; 56(1):55.
PMID: 39724438 DOI: 10.1007/s10735-024-10332-z.